Other Guidelines | Page 24 | European Cystic Fibrosis Society (ECFS)

Breakdown of lung proteins causes structural damage in cystic fibrosis lungs

Respiratory viral infections and chest CT (computer tomography scan) changes in infants with CF

The assessment of quality of care from the patient perspective

A rapid sweat test for chloride and bicarbonate to confirm the diagnosis of infants with cystic fibrosis

People with cystic fibrosis-related diabetes do not have a lower exercise capacity compared to those without diabetes: data from an international multicenter study

A Study Characterizing Sweat Chloride after CFTR Modulators in People with Cystic Fibrosis

Are we missing Aspergillus in airway samples due to bacteria that may also be present?

Eruption of brown moles following Trikafta/Kaftrio treatment for cystic fibrosis

Elexacaftor-Tezacaftor-Ivacaftor (ETI) improve stomach, gullet, nose and throat symptoms in people with advanced CF

ivacaftor does not change gut bacteria, inflammation or pancreas function

first
previous
…
20
21
22
23
24
25
26
27
28
…
next
last